These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33421689)
1. Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients. Vavougios GD; Ntoskas KT; Doskas TK Med Hypotheses; 2021 Feb; 147():110475. PubMed ID: 33421689 [TBL] [Abstract][Full Text] [Related]
2. The Impact of COVID-19 Disease on Platelets and Coagulation. Wool GD; Miller JL Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751 [TBL] [Abstract][Full Text] [Related]
3. Prothrombotic Phenotype in COVID-19: Focus on Platelets. Barale C; Melchionda E; Morotti A; Russo I Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438 [TBL] [Abstract][Full Text] [Related]
4. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Ahmad F; Kannan M; Ansari AW Cytokine Growth Factor Rev; 2022 Feb; 63():58-68. PubMed ID: 34750061 [TBL] [Abstract][Full Text] [Related]
5. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Iba T; Connors JM; Levy JH Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567 [TBL] [Abstract][Full Text] [Related]
6. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury. Rossouw TM; Anderson R; Manga P; Feldman C Front Immunol; 2022; 13():776861. PubMed ID: 35185878 [TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy. Cacciola R; Gentilini Cacciola E; Vecchio V; Cacciola E J Thromb Thrombolysis; 2022 Feb; 53(2):282-290. PubMed ID: 34687400 [TBL] [Abstract][Full Text] [Related]
9. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications. Tafazoli A; Anil Kumar S; Othman M Platelets; 2022 Jan; 33(1):48-53. PubMed ID: 34847829 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 coagulopathy: is it disseminated intravascular coagulation? Levi M; Iba T Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021 [TBL] [Abstract][Full Text] [Related]
11. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Iba T; Levy JH Trends Cardiovasc Med; 2022 Jan; 32(1):1-9. PubMed ID: 34455073 [TBL] [Abstract][Full Text] [Related]
12. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411 [TBL] [Abstract][Full Text] [Related]
13. Selenium Deficiency in COVID-19-A Possible Long-Lasting Toxic Relationship. Schomburg L Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057464 [TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications. Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168 [TBL] [Abstract][Full Text] [Related]
15. The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review. Agrati C; Sacchi A; Tartaglia E; Vergori A; Gagliardini R; Scarabello A; Bibas M Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360707 [TBL] [Abstract][Full Text] [Related]
16. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies. Gando S; Wada T Front Immunol; 2021; 12():649122. PubMed ID: 34177896 [TBL] [Abstract][Full Text] [Related]
18. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765 [TBL] [Abstract][Full Text] [Related]